Literature DB >> 22038421

Neuroleptic malignant syndrome during multiple antipsychotic therapy.

Margaret McDermott1, Douglas L Noordsy, Marcy Traum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22038421     DOI： 10.1007/s10597-011-9452-3

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN： 0010-3853


× No keyword cloud information.
  8 in total

1.  Neuroleptic malignant syndrome with aripiprazole and lithium: a case report.

Authors:  Syed Ali; Richard L Pearlman; Anu Upadhyay; Pankaj Patel
Journal:  J Clin Psychopharmacol       Date:  2006-08       Impact factor: 3.153

2.  Does antipsychotic polypharmacy increase the risk for metabolic syndrome?

Authors:  Christoph U Correll; Anne M Frederickson; John M Kane; Peter Manu
Journal:  Schizophr Res       Date:  2006-10-27       Impact factor: 4.939

3.  Neuroleptic malignant syndrome caused by combination of risperidone and lithium in a patient with multiple medical comorbidities.

Authors:  Seyfullah Gorkem Kosehasanogullari; Berna Akdede; Yildiz Akvardar; Mert Akan; Zeliha Tunca
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-04-24       Impact factor: 5.067

4.  Frequency and presentation of neuroleptic malignant syndrome in a state psychiatric hospital.

Authors:  P E Keck; J Sebastianelli; H G Pope; S L McElroy
Journal:  J Clin Psychiatry       Date:  1989-09       Impact factor: 4.384

5.  Frequency and presentation of neuroleptic malignant syndrome: a prospective study.

Authors:  P E Keck; H G Pope; S L McElroy
Journal:  Am J Psychiatry       Date:  1987-10       Impact factor: 18.112

6.  Ziprasidone- and lithium-induced neuroleptic malignant syndrome.

Authors:  Mary C Borovicka; Linda C Bond; Kerri M Gaughan
Journal:  Ann Pharmacother       Date:  2005-12-13       Impact factor: 3.154

7.  Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations.

Authors:  Lara S Picard; Shane Lindsay; Jeffrey R Strawn; Rakesh M Kaneria; Nick C Patel; Paul E Keck
Journal:  Pharmacotherapy       Date:  2008-04       Impact factor: 4.705

8.  Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital.

Authors:  H G Pope; P E Keck; S L McElroy
Journal:  Am J Psychiatry       Date:  1986-10       Impact factor: 18.112
  8 in total
  1 in total

1.  Serotonin syndrome with escitolapram and concomitant use of cocaine: a case report.

Authors:  Hamood Ur-Rehman Malik; Krishan Kumar
Journal:  Clin Med Insights Case Rep       Date:  2012-05-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.